Followers | 60 |
Posts | 5252 |
Boards Moderated | 1 |
Alias Born | 11/10/2009 |
Monday, April 28, 2014 8:39:35 AM
1.) and most crucial…is that no one took the bait on the "new drug" PR to move the PPS at all…so after a solid month or two, MCIC needed to go to the next step……the announcement alone did not provide any interest in the stock or budge the PPS
2. development sector is not impressed with the drugs target market……..not a lucrative segment for profitability... the medical world "skins the migraine cat" in 3 or 4 ways, all of which produce mediocre to sufficient results,
3.) this Migraine patent has ALREADY proven itself NOT TO BE the "magic bullet"……. takes MUCH MORE capability than MCIC possesses to FUND and MARKET such a drug… its not worth the COST need to bring to market…not worth developing….name the last successful drug to be FOUND and developed OUTSIDE of MEDIUM to BIG pharma..(which MCIC is neither a part of )…………..sorta tells ya MCIC is just fishin' the concept to see who "bites"
where have you seen that before????????????
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM